CLEVELAND, Ohio — A genomic test used to assess prostate cancer risk may also help doctors determine which patients are ...
Hologic has signed a definitive agreement to acquire Reveal Genomics, a Barcelona-based precision oncology company developing ...
Can a Cancer Genome Preserve Evidence of the Environmental Exposure That Helped Shape It? / Adam Butler, Anastassia Spiridou, ...
1don MSN
Cancer-promoting proteins may make tumors easier to spot but also help them evade immune attack
The immune system may recognize a cancer cell and still fail to destroy it. In a recent study, researchers at Hiroshima ...
Powered by whole-genome sequencing and MAESTRO* technology, the next-generation Oncodetect test takes a distinct approach to MRD, tracking up to 5,000 patient-specific variants with a limit ...
A new few-shot learning framework called scCAPReSE detects large-scale genomic rearrangements in single-cell Hi-C data using ...
A prospective trial found constitutional pathogenic variants in about 10 percent of solid tumor patients screened through ...
Researchers at the UCLA Health Jonsson Comprehensive Cancer Center have identified a new strategy to make cancer-fighting ...
OPTIMA shows Prosigna assay can help many ER-positive, HER2-negative breast cancer patients safely avoid chemotherapy.
New Prostate Cancer Approval Reinforces the Importance of Comprehensive Genomic Testing / cancer, FDA, genomic testing, ...
Two studies involving investigators at Cedars-Sinai Guerin Children’s and the University of Cambridge, U.K., highlight the ...
Computational biologist Christina Leslie, Ph.D., has spent nearly two decades at Memorial Sloan Kettering Cancer Center (MSK) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results